Literature DB >> 1866536

Serologic diagnosis of human brucellosis: analysis of 214 cases by agglutination tests and review of the literature.

E J Young1.   

Abstract

The serum agglutination test (SAT) and 2-mercaptoethanol (2ME) agglutination were used in studies of the sera of 214 patients in whom brucellosis was suspected. On the basis of historical, epidemiologic, clinical, and serologic data, four groups were identified: group I (108 cases) had negative agglutination reactions, and brucellosis was considered unlikely; group II (57 cases) had positive agglutination reactions, and active brucellosis was diagnosed; group III (37 cases) had positive agglutination reactions, but other factors--notably, a history of prior infection--made inactive brucellosis likely; and group IV (12 cases) had positive agglutination reactions, but insufficient data were available for further classification. Most patients with active brucellosis had agglutinin titers of greater than or equal to 160; however, no single titer was always diagnostic. Although more sensitive tests are available, agglutination reactions provide data sufficient to differentiate active from inactive disease when other factors are considered and follow-up sera are tested. This article discusses individual cases and reviews the literature on the diagnosis of brucellosis.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1866536     DOI: 10.1093/clinids/13.3.359

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  51 in total

1.  Posttreatment follow-Up of brucellosis by PCR assay.

Authors:  P Morata; M I Queipo-Ortuño; J M Reguera; M A García-Ordoñez; C Pichardo; J D Colmenero
Journal:  J Clin Microbiol       Date:  1999-12       Impact factor: 5.948

2.  Brucella abortus infection acquired in microbiology laboratories.

Authors:  P L Fiori; S Mastrandrea; P Rappelli; P Cappuccinelli
Journal:  J Clin Microbiol       Date:  2000-05       Impact factor: 5.948

3.  Diagnostic yield of a PCR assay in focal complications of brucellosis.

Authors:  P Morata; M I Queipo-Ortuño; J M Reguera; F Miralles; J J Lopez-Gonzalez; J D Colmenero
Journal:  J Clin Microbiol       Date:  2001-10       Impact factor: 5.948

4.  [A 37-year-old patient with fever, dyspnea and elevated transaminases after a stay in Mexico].

Authors:  Stephan A Schmid; Gabriele Birkenfeld
Journal:  Med Klin (Munich)       Date:  2010-04

5.  A comparison of Brucella IgG and IgM ELISA assays with agglutination methodology.

Authors:  Ryan J Welch; Christine M Litwin
Journal:  J Clin Lab Anal       Date:  2010       Impact factor: 2.352

6.  Evaluation of the PANBIO Brucella immunoglobulin G (IgG) and IgM enzyme-linked immunosorbent assays for diagnosis of human brucellosis.

Authors:  George F Araj; Mireille M Kattar; Layla G Fattouh; Kayane O Bajakian; Sara A Kobeissi
Journal:  Clin Diagn Lab Immunol       Date:  2005-11

7.  Bacteremic and nonbacteremic brucellosis: clinical and laboratory observations.

Authors:  A Kadanali; K Ozden; U Altoparlak; A Erturk; M Parlak
Journal:  Infection       Date:  2009-01-12       Impact factor: 3.553

8.  Real-time PCR for detection of Brucella spp. DNA in human serum samples.

Authors:  C Debeaumont; P A Falconnet; M Maurin
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-12       Impact factor: 3.267

9.  Brucellosis in a returned traveller.

Authors:  Andrew Di Pierdomenico; Sergio M Borgia; David Richardson; Mahin Baqi
Journal:  CMAJ       Date:  2011-03-07       Impact factor: 8.262

10.  Brucellosis among hospitalized febrile patients in northern Tanzania.

Authors:  Andrew J Bouley; Holly M Biggs; Robyn A Stoddard; Anne B Morrissey; John A Bartlett; Isaac A Afwamba; Venance P Maro; Grace D Kinabo; Wilbrod Saganda; Sarah Cleaveland; John A Crump
Journal:  Am J Trop Med Hyg       Date:  2012-10-22       Impact factor: 2.345

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.